Pasithea Therapeutics Corp. (KTTA)

NASDAQ: KTTA · Real-Time Price · USD

0.4494

-0.0006 (-0.13%)

Jul 29, 2026, 11:32 AM EDT - Market open

Pasithea Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	15	30	4	8	17	41
Market Cap Growth	177.87%	578.23%	-43.02%	-53.90%	-58.94%	-
Enterprise Value	-35.36	-25.47	-2.53	-8.54	-15.86	-12.24
Last Close Price	0.45	1.29	3.15	7.40	12.84	35.40

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	-	-	-	-	-	2703.81
PB Ratio	0.20	0.54	0.30	0.33	0.39	0.79
P/TBV Ratio	0.11	0.18	0.56	0.64	0.50	0.36

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	-	-	-	-	-	-812.77
EV/EBITDA Ratio	-	1.26	0.19	0.56	1.26	2.72
EV/EBIT Ratio	-	1.22	0.18	0.53	1.26	2.72
EV/FCF Ratio	-	1.67	0.18	0.66	1.32	3.83

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-	0	0	0	0.01	0
Net Debt / Equity Ratio	-0.92	-1.00	-0.47	-0.69	-0.77	-1.03
Net Debt / EBITDA Ratio	2.36	2.74	0.51	1.06	2.59	11.76
Net Debt / FCF Ratio	2.98	3.63	0.50	1.26	2.72	16.58
Asset Turnover	-	0	0	0	0	0.00
Quick Ratio	33.91	11.11	6.18	6.22	17.62	118.42
Current Ratio	35.40	11.35	6.58	6.34	18.15	119.17
Return on Equity (ROE)	-35.87%	-58.36%	-72.83%	-47.07%	-24.97%	-8.45%
Return on Assets (ROA)	-37.83%	-54.67%	-67.56%	-44.82%	-25.56%	-16.91%
Return on Invested Capital (ROIC)	-541.53%	-334.32%	-156.57%	-153.87%	-223.13%	-44796.40%
Return on Capital Employed (ROCE)	-40.05%	-59.41%	-74.17%	-47.85%	-26.18%	-17.05%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Buyback Yield / Dilution	-804.92%	-541.47%	10.64%	2.83%	-142.65%	-116.58%
Total Shareholder Return	-804.92%	-541.47%	10.64%	2.83%	-142.65%	-116.58%

SEC Filings: 10-K · 10-Q